Company: GEHC
Filing Date: 2025-12-02
Form Type: 424B2
Source: 0001193125-25-305442
Chunk: 84

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-12-02
Form: 424B2
Chunk 84
---
within the meaning specified under the Trust Indenture Act), it will be required to eliminate the conflict
or resign. (Section 608)

19

DESCRIPTION OF WARRANTS

We may sell warrants to purchase our debt securities, shares of preferred stock, or shares of our common stock. In a prospectus supplement, we
will inform you of the exercise price and other specific terms of the warrants, including whether our or your obligations, if any, under any warrants may be satisfied by delivering or purchasing the underlying securities or their cash value.

DESCRIPTION OF UNITS

We may issue units comprising two or more securities described in this prospectus in any combination. The particular terms of the units will
be described in the applicable prospectus supplement, including, to the extent applicable, the designation and terms of the units and the securities comprising the units, including whether and under what circumstances those securities may be held or
transferred separately, any provision for the issuance, payment, settlement, transfer, or exchange of the units or of the securities comprising the units and whether the units will be issued in fully registered or global form.

20

PLAN OF DISTRIBUTION We may sell the securities offered pursuant to this prospectus in any of the following ways:

| • |     | directly to one or more purchasers; |

| • |     | through agents; |

| • |     | through underwriters or dealers; or |

| • |     | through a combination of any of these methods of sale. |

The distribution of the securities may be made from time to time in one or more transactions at a fixed price or prices, which may be changed, at market prices prevailing at the time of sale, at prices related to these prevailing market prices or at negotiated prices. A prospectus supplement with respect to each offering of securities will state the terms of the offering of the securities, including:

| • |     | the name or names of any underwriters, dealers, agents, or direct purchasers and the amounts of securities 
 underwritten or purchased by each of them, if any;                                                         |

| • |     | the public offering price or purchase price of the securities and the net proceeds to be received by us from the 
 sale;                                                                                                            |

| • |     | any delayed delivery arrangements; |

| • |     | any underwriting discounts or agency fees and other items constituting underwriters’ or agents’ 
 compensation; and                                                                               |

| • |     | any discounts or concessions allowed or reallowed or paid to dealers. |

21

LEGAL